ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers—Does One Size Fit All?

被引：0
|
作者：
Kristen E. Rhodin
Michael E. Lidsky
机构：
[1] Duke University Medical Center,Department of Surgery
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4822 / 4823
页数：1
相关论文
共 50 条
  • [11] Fluoropyrimidine-based adjuvant chemotherapy in patients with resected biliary tract cancers.
    Go, Se-il
    Kang, Jung Hun
    Jeong, Chi-Young
    Lee, Gyeong-won
    Kim, Hoon-Gu
    Kang, Myoung-Hee
    Song, Haa-na
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [12] Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract Cancers
    Kristen E. Rhodin
    Annie Liu
    Alex Bartholomew
    Ryan Kramer
    Anika Parameswaran
    Hope Uronis
    John Strickler
    David Hsu
    Michael A. Morse
    Kevin N. Shah
    Garth Herbert
    Sabino Zani
    Daniel P. Nussbaum
    Peter J. Allen
    Michael E. Lidsky
    Annals of Surgical Oncology, 2023, 30 : 4813 - 4821
  • [13] Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis
    Ghidini, Michele
    Tomasello, Gianluca
    Botticelli, Andrea
    Barni, Sandro
    Zabbialini, Giampietro
    Seghezzi, Silvia
    Passalacqua, Rodolfo
    Braconi, Chiara
    Petrelli, Fausto
    HPB, 2017, 19 (09) : 741 - 748
  • [14] „One size does not fit all“One size does not fit all
    S. Bercker
    S. Laudi
    S. N. Stehr
    Der Anaesthesist, 2017, 66 (10) : 735 - 736
  • [15] Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers
    Ma, Wen-Jie
    Jin, Yan-Wen
    Wu, Zhen-Ru
    Yang, Qin
    Wang, Jun-Ke
    Liu, Fei
    Shi, Yu-Jun
    Li, Quan-Sheng
    Cheng, Nan-Sheng
    HPB, 2020, 22 (07) : 939 - 949
  • [16] Author Correction: One size does not fit all for mutational signatures
    Giovanni Ciriello
    Nature Cancer, 2020, 1 : 469 - 469
  • [17] ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer
    Turner, Kevin M.
    Patel, Sameer H.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4620 - 4621
  • [18] ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer
    Kevin M. Turner
    Sameer H. Patel
    Annals of Surgical Oncology, 2022, 29 : 4620 - 4621
  • [19] Adjuvant chemotherapy for rectal cancer after preoperative radiation or chemoradiation: One size does not fit all
    Cervantes, A.
    Glynne-Jones, R.
    ANNALS OF ONCOLOGY, 2015, 26 (04) : 617 - 619
  • [20] ADJUVANT CHEMOTHERAPY FOR RESECTED BILIARY TRACT CANCER: A RETROSPECTIVE ANALYSIS
    Caponi, S.
    Lucchesi, M.
    Vasile, E.
    Caparello, C.
    Ginocchi, L.
    Lencioni, M.
    Ricci, S.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 262 - 262
12345